Flexible Work, Better Balance
Autolus is a biopharmaceutical company advancing innovative therapies for cancer and autoimmune diseases. It focuses on next‑generation programmed T‑cell therapies and has a pipeline covering haematological malignancies, solid tumours, and autoimmune conditions.
The Executive Medical Director (UK) will build and direct the United Kingdom Medical Affairs strategy for Autolus products, leading scientific communication, KOL engagement, advisory boards, investigator‑initiated trials, and evidence generation to support patient access and outcomes.